Evidence map›Paper›PMID 27039252›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology

Makings of a brittle bone: Unexpected lessons from a low protein diet study of a mouse OI model.

E L Mertz, E Makareeva, L S Mirigian, K Y Koon, J E Perosky, K M Kozloff, S Leikin

Open access · greenAbstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Extracellular matrix: The driving force of mammalian diseases.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

E L MertzSection on Physical Biochemistry, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
E MakareevaSection on Physical Biochemistry, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
L S MirigianSection on Physical Biochemistry, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
K Y KoonSection on Physical Biochemistry, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
J E PeroskyDepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
K M KozloffDepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
S LeikinSection on Physical Biochemistry, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: leikins@mail.nih.gov.
Eunice Kennedy Shriver National Institute of Child Health and Human Development · USUniversity of Michigan–Ann Arbor · USNational Institutes of Health · US

Funding

Collagen-related diseases ZIAHD000256 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI LEIKIN, SERGEY · 2009 to 2025
$19.7M
PHYSICAL PRINCIPLES OF BIOMOLECULAR RECOGNITION, SELF-ASSEMBLY AND REGULATIONZ01HD000256 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI LEIKIN, SERGEY · 1998 to 2008
$2.6M
High-definition infrared micro-spectroscopic imaging of biomaterialsZIAHD008810 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI LEIKIN, SERGEY · 2009 to 2022
$2.5M
Sclerostin Antibody Therapy for Treatment of Osteogenesis ImperfectaR01AR062522 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOZLOFF, KENNETH M · 2012 to 2016
$1.8M
Intramural NIH HHS Z01 HD000256NIAMS NIH HHS R01 AR062522NICHD NIH HHS ZIA HD008810
6 · The paper itself

Abstract

Glycine substitutions in type I collagen appear to cause osteogenesis imperfecta (OI) by disrupting folding of the triple helix, the structure of which requires Gly in every third position. It is less clear, however, whether the resulting bone malformations and fragility are caused by effects of intracellular accumulation of misfolded collagen on differentiation and function of osteoblasts, effects of secreted misfolded collagen on the function of bone matrix, or both. Here we describe a study originally conceived for testing how reducing intracellular accumulation of misfolded collagen would affect mice with a Gly610 to Cys substitution in the triple helical region of the α2(I) chain. To stimulate degradation of misfolded collagen by autophagy, we utilized a low protein diet. The diet had beneficial effects on osteoblast differentiation and bone matrix mineralization, but also affected bone modeling and suppressed overall animal growth. Our more important observations, however, were not related to the diet. They revealed how altered osteoblast function and deficient bone formation by each cell caused by the G610C mutation combined with increased osteoblastogenesis might make the bone more brittle, all of which are common OI features. In G610C mice, increased bone formation surface compensated for reduced mineral apposition rate, resulting in normal cortical area and thickness at the cost of altering cortical modeling process, retaining woven bone, and reducing the ability of bone to absorb energy through plastic deformation. Reduced collagen and increased mineral density in extracellular matrix of lamellar bone compounded the problem, further reducing bone toughness. The latter observations might have particularly important implications for understanding OI pathophysiology and designing more effective therapeutic interventions.

Indexed as

AnimalsCalcification, PhysiologicCell DifferentiationCollagen Type IDiet, Protein-RestrictedDisease Models, AnimalHumansMiceMutationOsteoblastsOsteogenesis ImperfectaProtein FoldingCol1a2 protein, mouseCollagen Type IBiomechanicsBoneCollagenMineralizationOsteogenesis imperfectaRaman microspectroscopy

Identifiers

PMID27039252
PMCPMC5061452
OpenAlexW2323547571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.